Lazard Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,700	Closed	-$76K	–	2635
2022 Q1	$76K	Buy	+4,700	New	+$76K	﹤0.01%	1528
2020 Q3	–	Sell	-2,894	Closed	-$33K	–	1778
2020 Q2	$33K	Buy	+2,894	New	+$33K	﹤0.01%	1338